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Background: Hepatitis B (HB) infection, caused by Hepatitis B
virus (HBV), is a major public health problem in South Africa (SA).
HBV is a blood-borne virus, thus healthcare workers (HCWs) are
at high risk of occupational exposure to HBV. This study aimed to
investigate in HCWs working in Gauteng.
Methods & Materials: HCWs’ serum samples were screened
for HB surface antigen (HBsAg), antibody to HBsAg (anti-HBs),
and antibodies to HB core antigen (anti-HBc) using the Elecsys
2010 electrochemiluminescence immunoassay (Roche Diagnos-
tics, Penzburg, Germany). HBV deoxyribonucleic acid (DNA) was
extractedusing theHighPureViralNucleicAcidKit (RocheDiagnos-
tics, Penzburg, Germany) and ampliﬁed using real time polymerase
chain reaction (PCR) (LightCycler Software Version 4.1, RocheDiag-
nostics, Penzberg, Germany). Data were collected using Microsoft
Access (Microsoft Ofﬁce, 2010) and analysed using Epi Info Version
6.04 (CDC, 2004).
Results:Of all HCWs, 28.8% (68/236)were susceptible (negative
for allHBVmarkers); 49.6% (117/236)were immunedue tovaccina-
tion (anti-HBs positive only); 12.7% (30/237) were immune due to
natural infection (anti-HBs and anti-HBc positive); 21.6% (51/236)
were exposed to natural infection (positive for either HBsAg, anti-
HBc, or HBV DNA); 8.1% (19/236) were infected (positive for either
HBsAg orHBVDNA); 7.2% (17/237)wereHBVDNApositive positive.
Conclusion: Over 7% of these HCWs have active HBV infections,
posing a risk to their patients. Also, 28.8% are susceptible to acquir-
ing HBV infection from their patients. Thus there is a need for a
vaccination policy for HCWs that protects both themselves and
their patients.
http://dx.doi.org/10.1016/j.ijid.2014.03.1070
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Background: Worldwide approximately 240 million people
have chronic hepatitis B virus (HBV) infection. The majority
of chronic infections are acquired either from mother-to-child
transmission (MTCT) or in early childhood. In South Africa, HBV
immunization is given at sixweeks of age. This is too late to prevent
vertical transmission of HBV. This study aimed to determine the
prevalenceofHBV infection inbabiesborn toHIV-infectedmothers.
Methods & Materials: A total of 916 samples were collected
from infants born to HIV-infected mothers in Johannesburg, Dur-
banandCapeTown, SouthAfrica.Data collection tookplace at study
entry and together with blood sampling at 25 and 60 weeks of
age. The data includes HIV status, mode of delivery, birth weight,
CD4 count, nutritional status,HBV immunization status.HBVmark-
ers (HBsAg, anti-HBs and anti-HBc) and anti-HCV antibodies were
tested on the Architect (Abbott). All HBsAg positive samples were
neutralized for conﬁrmation. Conﬁrmed HBsAg-positive samples
were tested for HBV DNA and quantiﬁed against a WHO standard
to determineHBV loads. HBV strain characterisation by sequencing
of the HBsAg gene and genotyping by phylogenetic analysis using
HepSEQ (www.hepseq.org.uk) is being done.
Results: Of the 916 samples at 60 weeks of age, 852 were avail-
able for testing. Our preliminary data shows that of these, three
samples are HBsAg positive with high HBV viral loads. An addi-
tional two samples show evidence of past HBV infection. Further
testing on 25 week samples from these infants will be performed
to determine timing of infection and sequencing will be performed
at both time points. The mothers of these infants will be traced and
tested.
Conclusion: This study provides evidence of HBV infection in
the infants of HIV-infected mothers in the era of HBV vaccination.
http://dx.doi.org/10.1016/j.ijid.2014.03.1071
